HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Total Debt (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Total Debt came in at $94.5 million in Q2 2026, up 1.14% year-over-year from $93.4 million in Q2 2025, and up 1.45% quarter-over-quarter from $93.2 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Total Debt (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Total Debt for 12 consecutive years, with $94.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Debt rose 1.14% year-over-year to $94.5 million in Q2 2026; TTM through Jun 2026 was $94.5 million, a 1.14% increase from a year earlier, with the FY2025 full-year figure at $93.2 million, up 12.5% from the prior year.
  • Total Debt was $94.5 million for Q2 2026 at HUTCHMED (China), up from $93.2 million in the prior quarter.
  • Over five years, Total Debt peaked at $94.5 million in Q2 2026 and troughed at $2.5 million in Q2 2022.
  • A 5-year average of $67.6 million and a median of $82.1 million in 2024 frame the typical range for Total Debt.
  • Across the five-year window, Total Debt plunged 90.92% in 2022 and soared 1597.74% in 2023, its largest moves.
  • Over 5 years, Total Debt stood at $38.3 million in 2022, then jumped by 107.12% to $79.3 million in 2023, then advanced by 4.36% to $82.8 million in 2024, then climbed by 12.5% to $93.2 million in 2025, then gained by 1.45% to $94.5 million in 2026.
  • The last three Total Debt figures came in at $94.5 million (Q2 2026), $93.2 million (Q4 2025), and $93.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn 62.75 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn 28.66 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn 1.99 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn -
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn 591.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn -
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 8.09 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 94.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.51 Mn
Dec 31, 2025 93.16 Mn
Jun 30, 2025 93.44 Mn
Dec 31, 2024 82.81 Mn
Jun 30, 2024 82.10 Mn
Dec 31, 2023 79.34 Mn
Jun 30, 2023 42.10 Mn
Dec 31, 2022 38.31 Mn
Jun 30, 2022 2.48 Mn
Dec 31, 2021 28.82 Mn
Jun 30, 2021 27.31 Mn
Mar 31, 2021 26.87 Mn
Dec 31, 2020 54.12 Mn
Jun 30, 2020 26.84 Mn
Dec 31, 2019 27.18 Mn
Sep 30, 2019 1.50 Mn
Jun 30, 2019 2.80 Mn
Mar 31, 2019 34.18 Mn
Dec 31, 2018 33.68 Mn
Jun 30, 2018 37.38 Mn